Reduced GABAA, slow synaptic inhibition in Alzheimer's disease

被引:0
|
作者
Maciver, M. Bruce [1 ]
Pearce, Robert A. [2 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Univ Wisconsin Madison, Madison, WI USA
关键词
Alzheimer's disease; brain; central nervous system; central nervous system agents; dementia; electrophysiology; GABA agents; hormones; insulin; mouse models; HIPPOCAMPAL;
D O I
10.1177/13872877251328940
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Altered synaptic physiology clearly contributes to memory loss and other CNS symptoms in Alzheimer's disease. A new paper in this issue of the Journal of Alzheimer's Disease, from Zhe Jin's group in Uppsala, Sweden, adds important new information to help us understand how. A powerful, yet largely uncharacterized form of neuronal inhibition-GABA(A, slow) synaptic current-was studied using whole-cell recordings in hippocampal brain slices from AD model mice (tg-APPSwe). The investigators found that GABA(A, slow) inhibition was significantly reduced in dentate granule neurons from aged AD mice, compared to both wild type and adult non-aged AD mice. This reduction would nicely explain the change in excitatory-inhibitory balance previously reported in this and other AD model animals, as well as impairments in pattern separation and theta-gamma cross-frequency coupling that are early manifestations of AD.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Synaptic degeneration in Alzheimer's disease
    Arendt, Thomas
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 167 - 179
  • [2] Synaptic Dysfunction in Alzheimer's Disease
    Marcello, Elena
    Epis, Roberta
    Saraceno, Claudia
    Di Luca, Monica
    SYNAPTIC PLASTICITY: DYNAMICS, DEVELOPMENT AND DISEASE, 2012, 970 : 573 - 601
  • [3] Synaptic degeneration in Alzheimer’s disease
    Thomas Arendt
    Acta Neuropathologica, 2009, 118 : 167 - 179
  • [4] mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer's disease in an APOE genotype-dependent manner
    Sanganahalli, Basavaraju G.
    Mihailovic, Jelena M.
    Vekaria, Hemendra J.
    Coman, Daniel
    Yackzan, Andrew T.
    Flemister, Abeoseh
    Aware, Chetan
    Wenger, Kathryn
    Hubbard, W. Brad
    Sullivan, Patrick G.
    Hyder, Fahmeed
    Lin, Ai-Ling
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2024, 44 (10) : 1745 - 1758
  • [5] Biomarkers of synaptic degeneration in Alzheimer's disease
    Cheng, Qian
    Fan, Yiou
    Zhang, Pengfei
    Liu, Huan
    Han, Jialin
    Yu, Qian
    Wang, Xueying
    Wu, Shuang
    Lu, Zhiming
    AGEING RESEARCH REVIEWS, 2025, 104
  • [6] Compensating for synaptic loss in Alzheimer's disease
    Abuhassan, Kamal
    Coyle, Damien
    Belatreche, Ammar
    Maguire, Liam
    JOURNAL OF COMPUTATIONAL NEUROSCIENCE, 2014, 36 (01) : 19 - 37
  • [7] The role of synaptic microRNAs in Alzheimer's disease
    Kumar, Subodh
    Reddy, P. Hemachandra
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (12):
  • [8] GABAA receptors in aging and Alzheimer's disease
    Rissman, Robert A.
    De Blas, Angel L.
    Armstrong, David M.
    JOURNAL OF NEUROCHEMISTRY, 2007, 103 (04) : 1285 - 1292
  • [9] Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus
    Hoffman, AF
    Lupica, CR
    JOURNAL OF NEUROSCIENCE, 2000, 20 (07) : 2470 - 2479
  • [10] Epigenetic regulation of synaptic disorder in Alzheimer's disease
    Chen, Zhiying
    Wu, Moxin
    Lai, Qin
    Zhou, Weixin
    Wen, Xiaoqing
    Yin, Xiaoping
    FRONTIERS IN NEUROSCIENCE, 2022, 16